JP2008539215A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008539215A5 JP2008539215A5 JP2008508290A JP2008508290A JP2008539215A5 JP 2008539215 A5 JP2008539215 A5 JP 2008539215A5 JP 2008508290 A JP2008508290 A JP 2008508290A JP 2008508290 A JP2008508290 A JP 2008508290A JP 2008539215 A5 JP2008539215 A5 JP 2008539215A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- heteroaryl
- optionally substituted
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0508471.0A GB0508471D0 (en) | 2005-04-26 | 2005-04-26 | Therapeutic agents |
| GB0508471.0 | 2005-04-26 | ||
| PCT/GB2006/001505 WO2006114606A1 (en) | 2005-04-26 | 2006-04-25 | Fused thiazole derivatives as kinase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008539215A JP2008539215A (ja) | 2008-11-13 |
| JP2008539215A5 true JP2008539215A5 (enExample) | 2012-08-30 |
| JP5243953B2 JP5243953B2 (ja) | 2013-07-24 |
Family
ID=34640185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008508290A Active JP5243953B2 (ja) | 2005-04-26 | 2006-04-25 | キナーゼ阻害剤としての縮合チアゾール誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7888344B2 (enExample) |
| EP (1) | EP1881827B1 (enExample) |
| JP (1) | JP5243953B2 (enExample) |
| AT (1) | ATE526021T1 (enExample) |
| AU (1) | AU2006239018B2 (enExample) |
| CA (1) | CA2607426C (enExample) |
| ES (1) | ES2373680T3 (enExample) |
| GB (1) | GB0508471D0 (enExample) |
| WO (1) | WO2006114606A1 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2035436B1 (en) * | 2006-06-26 | 2011-05-25 | UCB Pharma S.A. | Fused thiazole derivatives as kinase inhibitors |
| GB0620059D0 (en) | 2006-10-10 | 2006-11-22 | Ucb Sa | Therapeutic agents |
| GB0620818D0 (en) * | 2006-10-19 | 2006-11-29 | Ucb Sa | Therapeutic agents |
| WO2008060597A2 (en) | 2006-11-15 | 2008-05-22 | Vertex Pharmaceuticals Incorporated | Compounds useful as protein kinase inhibitors |
| CN101616672A (zh) | 2007-02-20 | 2009-12-30 | 诺瓦提斯公司 | 作为脂质激酶和mTOR双重抑制剂的咪唑并喹啉类 |
| US7893060B2 (en) | 2007-06-12 | 2011-02-22 | F. Hoffmann-La Roche Ag | Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase |
| NZ581919A (en) | 2007-06-26 | 2011-08-26 | Ucb Pharma Sa | Fused thiazole derivatives as kinase inhibitors |
| WO2009036768A2 (en) * | 2007-09-19 | 2009-03-26 | H. Lundbeck A/S | Diagnosing potential weight gain in a subject |
| ES2399774T3 (es) | 2007-09-24 | 2013-04-03 | Genentech, Inc. | Compuestos de tiazolopirimidina inhibidores de PI3K y métodos de uso |
| JP5348725B2 (ja) | 2007-10-25 | 2013-11-20 | ジェネンテック， インコーポレイテッド | チエノピリミジン化合物の製造方法 |
| GB0723747D0 (en) * | 2007-12-04 | 2008-12-31 | Ucb Pharma Sa | Therapeutic agents |
| WO2009071895A1 (en) * | 2007-12-04 | 2009-06-11 | Ucb Pharma S.A. | Fused thiazole and thiophene derivatives as kinase inhibitors |
| WO2009071890A1 (en) * | 2007-12-04 | 2009-06-11 | Ucb Pharma S.A. | Tricyclic kinase inhibitors |
| US9029411B2 (en) | 2008-01-25 | 2015-05-12 | Millennium Pharmaceuticals, Inc. | Thiophenes and uses thereof |
| WO2009120826A1 (en) * | 2008-03-27 | 2009-10-01 | Wyeth | 2-aryl- and 2-heteroarylthiazolyl compounds, methods for their preparation and use thereof |
| GB0805818D0 (en) * | 2008-03-31 | 2008-04-30 | Ucb Pharma Sa | Therapeutic agents |
| US8796314B2 (en) | 2009-01-30 | 2014-08-05 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| EP2391619A1 (en) | 2009-01-30 | 2011-12-07 | Millennium Pharmaceuticals, Inc. | Heteroaryls and their use as pi3k inhibitors |
| US9090601B2 (en) | 2009-01-30 | 2015-07-28 | Millennium Pharmaceuticals, Inc. | Thiazole derivatives |
| US8410095B2 (en) | 2009-05-20 | 2013-04-02 | Glaxosmithkline Llc | Thiazolopyrimidinone derivatives as PI3 kinase inhibitors |
| US8158625B2 (en) | 2009-05-27 | 2012-04-17 | Genentech, Inc. | Bicyclic indole-pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use |
| WO2010138589A1 (en) | 2009-05-27 | 2010-12-02 | Genentech, Inc. | Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use |
| US9062038B2 (en) | 2010-08-11 | 2015-06-23 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| SG10201506238SA (en) | 2010-08-11 | 2015-09-29 | Millennium Pharm Inc | Heteroaryls And Uses Thereof |
| US8859768B2 (en) | 2010-08-11 | 2014-10-14 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| PE20141044A1 (es) * | 2010-10-13 | 2014-09-07 | Millennium Pharm Inc | Heteroarilos y sus usos |
| CA2828415A1 (en) | 2011-03-10 | 2012-09-13 | Lupin Limited | Substituted morpholines as modulators for the calcium sensing receptor |
| SG10201707002VA (en) | 2013-05-01 | 2017-10-30 | Hoffmann La Roche | Biheteroaryl compounds and uses thereof |
| WO2017156350A1 (en) | 2016-03-09 | 2017-09-14 | K-Gen, Inc. | Methods of cancer treatment |
| CN107556199A (zh) * | 2017-09-24 | 2018-01-09 | 杨子辉 | 一种3,4‑二氯‑2‑氨基‑5‑氟联苯的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7091227B2 (en) * | 2000-02-07 | 2006-08-15 | Abbott Gmbh & Co. Kg | Benzothiazole derivatives |
| WO2001083456A1 (en) * | 2000-04-27 | 2001-11-08 | Yamanouchi Pharmaceutical Co., Ltd. | Condensed heteroaryl derivatives |
| US7176214B2 (en) * | 2003-05-21 | 2007-02-13 | Bristol-Myers Squibb Company | Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
-
2005
- 2005-04-26 GB GBGB0508471.0A patent/GB0508471D0/en not_active Ceased
-
2006
- 2006-04-25 WO PCT/GB2006/001505 patent/WO2006114606A1/en not_active Ceased
- 2006-04-25 AU AU2006239018A patent/AU2006239018B2/en not_active Ceased
- 2006-04-25 JP JP2008508290A patent/JP5243953B2/ja active Active
- 2006-04-25 CA CA2607426A patent/CA2607426C/en active Active
- 2006-04-25 AT AT06726894T patent/ATE526021T1/de not_active IP Right Cessation
- 2006-04-25 EP EP06726894A patent/EP1881827B1/en active Active
- 2006-04-25 US US11/912,801 patent/US7888344B2/en active Active
- 2006-04-25 ES ES06726894T patent/ES2373680T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008539215A5 (enExample) | ||
| JP2008538557A5 (enExample) | ||
| JP2005053931A5 (enExample) | ||
| JP2009515872A5 (enExample) | ||
| JP2008523126A5 (enExample) | ||
| JP2007508359A5 (enExample) | ||
| JP2008510828A5 (enExample) | ||
| JP2005523310A5 (enExample) | ||
| WO2005037781A3 (fr) | Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique | |
| JP2005529954A5 (enExample) | ||
| JP2010529147A5 (enExample) | ||
| JP2008044952A5 (enExample) | ||
| JP2011037841A5 (enExample) | ||
| JP2014507464A5 (enExample) | ||
| JP2012510502A5 (enExample) | ||
| WO2008006043A3 (en) | 1,3-oxazole derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents | |
| JP2006525293A5 (enExample) | ||
| CA2683059A1 (en) | Atropisomer of pyrrole derivative | |
| JP2005289914A5 (enExample) | ||
| MA32642B1 (fr) | Amides utiles en therapie | |
| JP2014526533A5 (enExample) | ||
| JP2013502441A5 (enExample) | ||
| JP2009504793A5 (enExample) | ||
| JP2007519618A5 (enExample) | ||
| JP2009184932A5 (enExample) |